The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 03, 2026 for Aayush Agrawal, trustee ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aayush Agrawal, acting as trustee of the Aayush Agrawal Trust, has created a pledge on 3,85,000 shares (0.31% of total share capital) of Ajanta Pharma Ltd. The pledge was created on March 30, 2026, with the reason stated as 'increase the loan'. This disclosure is filed under SEBI SAST Regulations, 2011 which governs substantial acquisition of shares and takeovers. The trust holds a total of 1,41,12,924 shares (11.30%) in the company, of which 83,96,662 shares (6.72%) are already encumbered. This new pledge adds 0.31% to the encumbered shares of this trust.
This pledge creation is relatively small (0.31%) and appears to be for personal borrowing by the trustee. While not alarming, pledge creations by promoters can indicate financial stress or borrowing needs, which investors should monitor for any pattern of increasing encumbrances.